Recent changes for Medicines Management

Drugs

• Ruxolitinib
• Lurasidone
• Pembrolizumab
• Idebenone
• Ribociclib
• Guselkumab
• Durvalumab
• Sacituzumab govitecan
• Tarlatamab
• Betula Verrucosa
• Clobetasol / neomycin / nystatin
• Pegzilarginase (Loargys)

JAPC Minutes

• August 2025 Log

JAPC Bulletins

• Bulletin Aug 2025

Prescribing Guidelines

• Antipsychotics - Prescribing and Management for mental health conditions
• DOAC Position Statement

General Information

• High Cost Drugs exc. from tariff

Recent changes for Clinical Policies

Not routinely commissioned

• Irritable Bowel Syndrome (IBS) - Psychological Interventions Position Statement

Clinical Policies - Cosmetic

• Scar Reduction (Hypertrophic and Keloid)